Figure 1. Percentage of Penicillin Non-Susceptible S

Slides:



Advertisements
Similar presentations
SWEDRES 2001 Figures and Tables. 3. Use of antimicrobials.
Advertisements

Percentage of Penicillin Non-Susceptible S. pneumoniae in Canada: Percentage of Penicillin Non-Susceptible S. pneumoniae in Canada:
Antimicrobial resistance surveillance in Ireland Results of invasive Streptococcus pneumoniae infection (blood/CSF) surveillance (2009Q1-4) **** Data as.
The Resistance Problem PRSP = Penicillin Resistant Strep. pneumoniae QRSP = Quinolone Resistant Strep. pneumoniae MRSA = Methicillin Resistant Staph.
Choosing Antimicrobials in Special Situations. Additional considerations in making a final antibiotic selection Site of action – (Will the antibiotic.
P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.
Overview of Use of PK-PD in Streamlining Drug Development William A. Craig Professor of Medicine University of Wisconsin.
Sexually Transmitted Disease Surveillance 2011 Division of STD Prevention.
Toronto Invasive Bacterial Diseases Network  Collaborative network of all hospital and largest private microbiology laboratories in metropolitan Toronto/Peel.
Expenditure Analysis of Criminal Justice in Canada Ottawa, Canada, March 2013.
Trevor Winstanley Rebecca Clarke Department of Microbiology
PAHO Pan American Health Organization Pan American Sanitary Bureau Regional Office for the Americas for the World Health Organization.
Epidemiology of invasive meningococcal disease in the Netherlands and impact of serogroup C vaccination National surveillance data (Netherlands Reference.
Evaluation of the resistance of bacterial pathogens of synopulmonary infections in children L.Chernyshova F.Lapiy National Medical Academy of Postgraduate.
Streptococcus pneumoniae Lecture 9 Summer, 2004 Demosthenes Pappagianis, MD MMI 480B.
Created byInformation Design A Mathematical Model for the Impact of the Conjugate Vaccine on S. pneumoniae Vaccine and Non-vaccine serotypes Robertino.
 decimals/cc-7th-fracs-to-decimals/v/converting-fractions-to-decimals-example.
Susceptibility Patterns over 3 years in Community-acquired Lower Respiratory Infection in the UK and Ireland R. Reynolds, D. Felmingham BSAC Working Party.
Nosocomial E. coli Urine Isolates 1991 – Nosocomial K. pneumoniae Urine Isolates
Nosocomial E. coli Urine Isolates Nosocomial K. pneumoniae Urine Isolates
Ocular TRUST 3: Ongoing Longitudinal Surveillance of Antimicrobial Susceptibility in Ocular Isolates Penny A. Asbell, MD, FACS, MBA 1 ; Daniel F. Sahm,
Figure 1. Rate of antimicrobial resistance in S. pneumoniae
Toronto Invasive Bacterial Diseases Network
Tuberculosis in the United States
World Tuberculosis Day 2014
EARS-Net data on Antimicrobial Resistance in Ireland, Q
* LABORATORY-BASED SURVEILLANCE OF S. PNEUMONIAE INVASIVE DISEASE (IPD) IN CHILDREN: SEROTYPE DISTRIBUTION AND ESTIMATION OF VACCINES COVERAGE B. V. M.
Table 1 Groups of subjects in a study of the association between antibiotic use and colonization with resistant pneumococci. From: Measuring and Interpreting.
Gonococcal Isolate Surveillance Project (GISP)
Ontario’s Pneumococcal Vaccination Program Allison McGeer
Toronto Invasive Bacterial Diseases Network
Ontario Group A Streptococcal Study
C-672b First report of Group B Streptococcus Isolates with Cross-resistance to Lincosamides, Streptogramin A, and Pleuromutilins in the United States P.
at George Washington University Medical Center, Washington, DC
Antibiotic resistance and serotype distribution of nasopharyngeal isolates of Streptococcus pneumoniae from children in Marrakech region (Morocco)  Karima.
Tuberculosis in the United States
R. Leclercq  Clinical Microbiology and Infection 
Gonorrhea Sexually Transmitted Disease Surveillance 2010
In-vitro interaction of azithromycin and fluoroquinolones against gram-positive and gram-negative bacteria  Matthew W. Ruble, Deborah H. Gilbert, Stephen.
Ketolides: A New Class of Antibacterial Agents for Treatment of Community-Acquired Respiratory Tract Infections in a Primary Care Setting  Jeffrey Paul.
P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys 
The State of Pneumococcal Disease Prevention
World Tuberculosis Day 2014
Current patterns and evolution of antibiotic resistance among bacterial pathogens involved in acute otitis media  Fernando Baquero, Rafael Cantón, Fernando.
Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program  M.
Pneumococcal conjugate vaccines: overview of a decade from Kuwait
D.E. Low  Clinical Microbiology and Infection 
The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci  Keith Klugman, Fred Goldstein,
…monitoring trends in antimicrobial resistance in Canada
Prevalence of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae isolates reported by laboratories in the southern and eastern.
Carriage of resistant pneumococci by children in southern Israel and impact of conjugate vaccines on carriage  Ron Dagan, Drora Fraser, Noga Givon, Pablo.
M. Woodhead, F. Blasi, S. Ewig, J. Garau, G. Huchon, M. Ieven, A
Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan  P.-R. Hsueh, J.-M. Shyr, J.-J. Wu  Clinical.
Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic.
Percentage of Penicillin Non-Susceptible S
Figure 1. Percentage of Penicillin Non-Susceptible S
ANTIMICROBIAL USE AND RESISTANCE SURVEILLANCE PILOT PROJECT – LESSONS FROM THE DURBAN SITE Gray AL, Essack SY, Deedat F, Pillay T, van Maasdyk J, Holloway.
D. Felmingham, C. Feldman, W. Hryniewicz, K. Klugman, S. Kohno, D. E
Role of communicable disease control measures in affecting the spread of resistant pneumococci: the Swedish model  Karl Ekdahl, Otto Cars  Clinical Microbiology.
The prevalence of penicillin-non-susceptible Streptococcus pneumoniae among children aged < 5 years correlates with the biannual epidemic activity of.
…monitoring trends in antimicrobial resistance in Canada
M. Biçmen, Z. Gülay, S.V. Ramaswamy, D.M. Musher, D. Gür 
Modification of prescribers’ behavior: the Icelandic approach
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands  J.W. Mouton, A.R. Jansz  Clinical.
…monitoring trends in antimicrobial resistance in Canada
…monitoring trends in antimicrobial resistance in Canada
…monitoring trends in antimicrobial resistance in Canada
Fernando Baquero, John F
Age-standardized* prevalence and number of cases of diagnosed diabetes among individuals aged 1 year and older, Canada, 1998/99 to 2008/09. *Age-standardized.
Presentation transcript:

Figure 1. Percentage of Penicillin Non-Susceptible S Figure 1. Percentage of Penicillin Non-Susceptible S. pneumoniae in Canada: 1988-2005 Canadian Bacterial Surveillance Network, March 2006

Figure 2. Percentage of Non-susceptible Sterile Site vs Non-sterile Site Isolates of S. pneumoniae, 2005 Canadian Bacterial Surveillance Network, March 2006

Figure 3. Percentage of Non-susceptible Isolates of S Figure 3. Percentage of Non-susceptible Isolates of S. pneumoniae in Ages <=15 and >64, 2005 Canadian Bacterial Surveillance Network, March 2006

Figure 4. Percentage of Non-susceptible Isolates of S Figure 4. Percentage of Non-susceptible Isolates of S. pneumoniae in Geographic Regions of Canada, 2005 Canadian Bacterial Surveillance Network, March 2006

Figure 5. Macrolide-Resistant Pneumococci: Canadian Bacterial Surveillance Network, 1988-2005 Canadian Bacterial Surveillance Network, March 2006

Figure 6. Fluoroquinolone-Resistant Pneumococci: Canadian Bacterial Surveillance Network, 1997-2005 Canadian Bacterial Surveillance Network, March 2006

Figure 7. Fluoroquinolone-Resistant Pneumococci in Respiratory Isolates from Adults >64 years: 1988-2005 Canadian Bacterial Surveillance Network, March 2006

Figure 8. Ceftriaxone-Resistant Pneumococci: Canadian Bacterial Surveillance Network, 1988-2005 Canadian Bacterial Surveillance Network, March 2006 *Non-meningitis breakpoints used